0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Angiogenesis Assay Market Research Report 2026
Published Date: 2026-04-10
|
Report Code: QYRE-Auto-11S9277
Home | Market Reports
Global Angiogenesis Assay Market Size Status and Forecast 2022
BUY CHAPTERS

Global Angiogenesis Assay Market Research Report 2026

Code: QYRE-Auto-11S9277
Report
2026-04-10
Pages:115
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Angiogenesis Assay Market Size

The global Angiogenesis Assay market was valued at US$ 25.87 million in 2025 and is anticipated to reach US$ 42.62 million by 2032, at a CAGR of 7.5% from 2026 to 2032.

Angiogenesis Assay Market

Angiogenesis Assay Market

Angiogenesis is the tightly regulated process by which new blood vessels are formed from the existing vasculature. This process is physiologically important for development and wound healing, and is also a common driver in multiple diseases including rheumatoid arthritis, atherosclerosis, macular degeneration, and cancer. Angiogenesis occurs in response to a variety of molecular cues. Generally, the angiogenic process includes endothelial cell proliferation, chemotactic endothelial cell migration through the extracellular matrix barrier, and the formation of capillary tubes. Physiological and pathological angiogenesis utilize many of the same cellular processes and molecular signaling networks, however the structures that form during pathological angiogenesis are often functionally abnormal.
The global angiogenesis assay kit market has maintained steady growth in recent years, primarily driven by applications in oncology research, cardiovascular drug development, and organoid models. In terms of technology type, in vitro tube formation experiments dominate, while microfluidic 3D models, embracing the in vivo environment, are experiencing the fastest growth. Regarding pricing, high-end assays maintain high margins thanks to technological barriers, while Chinese manufacturers are rapidly penetrating the mid- and low-end markets through domestic substitution (reducing prices by 30%-50%). Regionally, North America is the largest global market for angiogenesis assay kits, holding over 35% of the market share, followed by Europe and Asia Pacific, which together hold nearly 60% of the market share. Due to cost sensitivity, the Asia Pacific market is seeing an increase in the share of local brands. In the future, as demand for precision medicine and anti-angiogenic drug development increases, highly sensitive, automated assays will become a key competitive focus. Furthermore, price competition in emerging markets is likely to further intensify industry consolidation.
This report delivers a comprehensive overview of the global Angiogenesis Assay market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Angiogenesis Assay. The Angiogenesis Assay market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Angiogenesis Assay market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Angiogenesis Assay manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Angiogenesis Assay Market Report

Report Metric Details
Report Name Angiogenesis Assay Market
Accounted market size in 2025 US$ 25.87 million
Forecasted market size in 2032 US$ 42.62 million
CAGR 7.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • In Vitro Assay Kit
  • In Vivo Assay Kit
Segment by Application
  • Academic Institution
  • Biotech Companies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abcam, Bio-Techne (Trevigen, R&D Systems), Thermo Fisher Scientific, Cell Biolabs, Inc., BioVision, Inc, PromoCell GmbH, Merck KGaA, Kollodis BioSciences, Sartorius (Essen BioScience), Creative Bioarray, ibidi GmbH, Solarbio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Angiogenesis Assay companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Angiogenesis Assay Market growing?

Ans: The Angiogenesis Assay Market witnessing a CAGR of 7.5% during the forecast period 2026-2032.

What is the Angiogenesis Assay Market size in 2032?

Ans: The Angiogenesis Assay Market size in 2032 will be US$ 42.62 million.

Who are the main players in the Angiogenesis Assay Market report?

Ans: The main players in the Angiogenesis Assay Market are Abcam, Bio-Techne (Trevigen, R&D Systems), Thermo Fisher Scientific, Cell Biolabs, Inc., BioVision, Inc, PromoCell GmbH, Merck KGaA, Kollodis BioSciences, Sartorius (Essen BioScience), Creative Bioarray, ibidi GmbH, Solarbio

What are the Application segmentation covered in the Angiogenesis Assay Market report?

Ans: The Applications covered in the Angiogenesis Assay Market report are Academic Institution, Biotech Companies

What are the Type segmentation covered in the Angiogenesis Assay Market report?

Ans: The Types covered in the Angiogenesis Assay Market report are In Vitro Assay Kit, In Vivo Assay Kit

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Angiogenesis Assay Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 In Vitro Assay Kit
1.2.3 In Vivo Assay Kit
1.3 Market by Application
1.3.1 Global Angiogenesis Assay Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Academic Institution
1.3.3 Biotech Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Angiogenesis Assay Market Perspective (2021–2032)
2.2 Global Angiogenesis Assay Growth Trends by Region
2.2.1 Global Angiogenesis Assay Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Angiogenesis Assay Historic Market Size by Region (2021–2026)
2.2.3 Angiogenesis Assay Forecasted Market Size by Region (2027–2032)
2.3 Angiogenesis Assay Market Dynamics
2.3.1 Angiogenesis Assay Industry Trends
2.3.2 Angiogenesis Assay Market Drivers
2.3.3 Angiogenesis Assay Market Challenges
2.3.4 Angiogenesis Assay Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Angiogenesis Assay Players by Revenue
3.1.1 Global Top Angiogenesis Assay Players by Revenue (2021–2026)
3.1.2 Global Angiogenesis Assay Revenue Market Share by Players (2021–2026)
3.2 Global Top Angiogenesis Assay Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Angiogenesis Assay Revenue
3.4 Global Angiogenesis Assay Market Concentration Ratio
3.4.1 Global Angiogenesis Assay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Angiogenesis Assay Revenue in 2025
3.5 Global Key Players of Angiogenesis Assay Head Offices and Areas Served
3.6 Global Key Players of Angiogenesis Assay, Products and Applications
3.7 Global Key Players of Angiogenesis Assay, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Angiogenesis Assay Breakdown Data by Type
4.1 Global Angiogenesis Assay Historic Market Size by Type (2021–2026)
4.2 Global Angiogenesis Assay Forecasted Market Size by Type (2027–2032)
5 Angiogenesis Assay Breakdown Data by Application
5.1 Global Angiogenesis Assay Historic Market Size by Application (2021–2026)
5.2 Global Angiogenesis Assay Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Angiogenesis Assay Market Size (2021–2032)
6.2 North America Angiogenesis Assay Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Angiogenesis Assay Market Size by Country (2021–2026)
6.4 North America Angiogenesis Assay Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Angiogenesis Assay Market Size (2021–2032)
7.2 Europe Angiogenesis Assay Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Angiogenesis Assay Market Size by Country (2021–2026)
7.4 Europe Angiogenesis Assay Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Angiogenesis Assay Market Size (2021–2032)
8.2 Asia-Pacific Angiogenesis Assay Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Angiogenesis Assay Market Size by Region (2021–2026)
8.4 Asia-Pacific Angiogenesis Assay Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Angiogenesis Assay Market Size (2021–2032)
9.2 Latin America Angiogenesis Assay Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Angiogenesis Assay Market Size by Country (2021–2026)
9.4 Latin America Angiogenesis Assay Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Angiogenesis Assay Market Size (2021–2032)
10.2 Middle East & Africa Angiogenesis Assay Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Angiogenesis Assay Market Size by Country (2021–2026)
10.4 Middle East & Africa Angiogenesis Assay Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Details
11.1.2 Abcam Business Overview
11.1.3 Abcam Angiogenesis Assay Introduction
11.1.4 Abcam Revenue in Angiogenesis Assay Business (2021–2026)
11.1.5 Abcam Recent Development
11.2 Bio-Techne (Trevigen, R&D Systems)
11.2.1 Bio-Techne (Trevigen, R&D Systems) Company Details
11.2.2 Bio-Techne (Trevigen, R&D Systems) Business Overview
11.2.3 Bio-Techne (Trevigen, R&D Systems) Angiogenesis Assay Introduction
11.2.4 Bio-Techne (Trevigen, R&D Systems) Revenue in Angiogenesis Assay Business (2021–2026)
11.2.5 Bio-Techne (Trevigen, R&D Systems) Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Angiogenesis Assay Introduction
11.3.4 Thermo Fisher Scientific Revenue in Angiogenesis Assay Business (2021–2026)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Cell Biolabs, Inc.
11.4.1 Cell Biolabs, Inc. Company Details
11.4.2 Cell Biolabs, Inc. Business Overview
11.4.3 Cell Biolabs, Inc. Angiogenesis Assay Introduction
11.4.4 Cell Biolabs, Inc. Revenue in Angiogenesis Assay Business (2021–2026)
11.4.5 Cell Biolabs, Inc. Recent Development
11.5 BioVision, Inc
11.5.1 BioVision, Inc Company Details
11.5.2 BioVision, Inc Business Overview
11.5.3 BioVision, Inc Angiogenesis Assay Introduction
11.5.4 BioVision, Inc Revenue in Angiogenesis Assay Business (2021–2026)
11.5.5 BioVision, Inc Recent Development
11.6 PromoCell GmbH
11.6.1 PromoCell GmbH Company Details
11.6.2 PromoCell GmbH Business Overview
11.6.3 PromoCell GmbH Angiogenesis Assay Introduction
11.6.4 PromoCell GmbH Revenue in Angiogenesis Assay Business (2021–2026)
11.6.5 PromoCell GmbH Recent Development
11.7 Merck KGaA
11.7.1 Merck KGaA Company Details
11.7.2 Merck KGaA Business Overview
11.7.3 Merck KGaA Angiogenesis Assay Introduction
11.7.4 Merck KGaA Revenue in Angiogenesis Assay Business (2021–2026)
11.7.5 Merck KGaA Recent Development
11.8 Kollodis BioSciences
11.8.1 Kollodis BioSciences Company Details
11.8.2 Kollodis BioSciences Business Overview
11.8.3 Kollodis BioSciences Angiogenesis Assay Introduction
11.8.4 Kollodis BioSciences Revenue in Angiogenesis Assay Business (2021–2026)
11.8.5 Kollodis BioSciences Recent Development
11.9 Sartorius (Essen BioScience)
11.9.1 Sartorius (Essen BioScience) Company Details
11.9.2 Sartorius (Essen BioScience) Business Overview
11.9.3 Sartorius (Essen BioScience) Angiogenesis Assay Introduction
11.9.4 Sartorius (Essen BioScience) Revenue in Angiogenesis Assay Business (2021–2026)
11.9.5 Sartorius (Essen BioScience) Recent Development
11.10 Creative Bioarray
11.10.1 Creative Bioarray Company Details
11.10.2 Creative Bioarray Business Overview
11.10.3 Creative Bioarray Angiogenesis Assay Introduction
11.10.4 Creative Bioarray Revenue in Angiogenesis Assay Business (2021–2026)
11.10.5 Creative Bioarray Recent Development
11.11 ibidi GmbH
11.11.1 ibidi GmbH Company Details
11.11.2 ibidi GmbH Business Overview
11.11.3 ibidi GmbH Angiogenesis Assay Introduction
11.11.4 ibidi GmbH Revenue in Angiogenesis Assay Business (2021–2026)
11.11.5 ibidi GmbH Recent Development
11.12 Solarbio
11.12.1 Solarbio Company Details
11.12.2 Solarbio Business Overview
11.12.3 Solarbio Angiogenesis Assay Introduction
11.12.4 Solarbio Revenue in Angiogenesis Assay Business (2021–2026)
11.12.5 Solarbio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Angiogenesis Assay Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of In Vitro Assay Kit
 Table 3. Key Players of In Vivo Assay Kit
 Table 4. Global Angiogenesis Assay Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Angiogenesis Assay Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Angiogenesis Assay Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Angiogenesis Assay Market Share by Region (2021–2026)
 Table 8. Global Angiogenesis Assay Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Angiogenesis Assay Market Share by Region (2027–2032)
 Table 10. Angiogenesis Assay Market Trends
 Table 11. Angiogenesis Assay Market Drivers
 Table 12. Angiogenesis Assay Market Challenges
 Table 13. Angiogenesis Assay Market Restraints
 Table 14. Global Angiogenesis Assay Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Angiogenesis Assay Market Share by Players (2021–2026)
 Table 16. Global Top Angiogenesis Assay Players by Tier (Tier 1, Tier 2, and Tier 3), based on Angiogenesis Assay Revenue, 2025
 Table 17. Ranking of Global Top Angiogenesis Assay Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Angiogenesis Assay Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Angiogenesis Assay, Headquarters and Area Served
 Table 20. Global Key Players of Angiogenesis Assay, Products and Applications
 Table 21. Global Key Players of Angiogenesis Assay, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Angiogenesis Assay Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Angiogenesis Assay Revenue Market Share by Type (2021–2026)
 Table 25. Global Angiogenesis Assay Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Angiogenesis Assay Revenue Market Share by Type (2027–2032)
 Table 27. Global Angiogenesis Assay Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Angiogenesis Assay Revenue Market Share by Application (2021–2026)
 Table 29. Global Angiogenesis Assay Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Angiogenesis Assay Revenue Market Share by Application (2027–2032)
 Table 31. North America Angiogenesis Assay Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Angiogenesis Assay Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Angiogenesis Assay Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Angiogenesis Assay Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Angiogenesis Assay Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Angiogenesis Assay Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Angiogenesis Assay Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Angiogenesis Assay Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Angiogenesis Assay Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Angiogenesis Assay Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Angiogenesis Assay Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Angiogenesis Assay Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Angiogenesis Assay Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Angiogenesis Assay Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Angiogenesis Assay Market Size by Country (US$ Million), 2027–2032
 Table 46. Abcam Company Details
 Table 47. Abcam Business Overview
 Table 48. Abcam Angiogenesis Assay Product
 Table 49. Abcam Revenue in Angiogenesis Assay Business (US$ Million), 2021–2026
 Table 50. Abcam Recent Development
 Table 51. Bio-Techne (Trevigen, R&D Systems) Company Details
 Table 52. Bio-Techne (Trevigen, R&D Systems) Business Overview
 Table 53. Bio-Techne (Trevigen, R&D Systems) Angiogenesis Assay Product
 Table 54. Bio-Techne (Trevigen, R&D Systems) Revenue in Angiogenesis Assay Business (US$ Million), 2021–2026
 Table 55. Bio-Techne (Trevigen, R&D Systems) Recent Development
 Table 56. Thermo Fisher Scientific Company Details
 Table 57. Thermo Fisher Scientific Business Overview
 Table 58. Thermo Fisher Scientific Angiogenesis Assay Product
 Table 59. Thermo Fisher Scientific Revenue in Angiogenesis Assay Business (US$ Million), 2021–2026
 Table 60. Thermo Fisher Scientific Recent Development
 Table 61. Cell Biolabs, Inc. Company Details
 Table 62. Cell Biolabs, Inc. Business Overview
 Table 63. Cell Biolabs, Inc. Angiogenesis Assay Product
 Table 64. Cell Biolabs, Inc. Revenue in Angiogenesis Assay Business (US$ Million), 2021–2026
 Table 65. Cell Biolabs, Inc. Recent Development
 Table 66. BioVision, Inc Company Details
 Table 67. BioVision, Inc Business Overview
 Table 68. BioVision, Inc Angiogenesis Assay Product
 Table 69. BioVision, Inc Revenue in Angiogenesis Assay Business (US$ Million), 2021–2026
 Table 70. BioVision, Inc Recent Development
 Table 71. PromoCell GmbH Company Details
 Table 72. PromoCell GmbH Business Overview
 Table 73. PromoCell GmbH Angiogenesis Assay Product
 Table 74. PromoCell GmbH Revenue in Angiogenesis Assay Business (US$ Million), 2021–2026
 Table 75. PromoCell GmbH Recent Development
 Table 76. Merck KGaA Company Details
 Table 77. Merck KGaA Business Overview
 Table 78. Merck KGaA Angiogenesis Assay Product
 Table 79. Merck KGaA Revenue in Angiogenesis Assay Business (US$ Million), 2021–2026
 Table 80. Merck KGaA Recent Development
 Table 81. Kollodis BioSciences Company Details
 Table 82. Kollodis BioSciences Business Overview
 Table 83. Kollodis BioSciences Angiogenesis Assay Product
 Table 84. Kollodis BioSciences Revenue in Angiogenesis Assay Business (US$ Million), 2021–2026
 Table 85. Kollodis BioSciences Recent Development
 Table 86. Sartorius (Essen BioScience) Company Details
 Table 87. Sartorius (Essen BioScience) Business Overview
 Table 88. Sartorius (Essen BioScience) Angiogenesis Assay Product
 Table 89. Sartorius (Essen BioScience) Revenue in Angiogenesis Assay Business (US$ Million), 2021–2026
 Table 90. Sartorius (Essen BioScience) Recent Development
 Table 91. Creative Bioarray Company Details
 Table 92. Creative Bioarray Business Overview
 Table 93. Creative Bioarray Angiogenesis Assay Product
 Table 94. Creative Bioarray Revenue in Angiogenesis Assay Business (US$ Million), 2021–2026
 Table 95. Creative Bioarray Recent Development
 Table 96. ibidi GmbH Company Details
 Table 97. ibidi GmbH Business Overview
 Table 98. ibidi GmbH Angiogenesis Assay Product
 Table 99. ibidi GmbH Revenue in Angiogenesis Assay Business (US$ Million), 2021–2026
 Table 100. ibidi GmbH Recent Development
 Table 101. Solarbio Company Details
 Table 102. Solarbio Business Overview
 Table 103. Solarbio Angiogenesis Assay Product
 Table 104. Solarbio Revenue in Angiogenesis Assay Business (US$ Million), 2021–2026
 Table 105. Solarbio Recent Development
 Table 106. Research Programs/Design for This Report
 Table 107. Key Data Information from Secondary Sources
 Table 108. Key Data Information from Primary Sources
 Table 109. Authors List of This Report


List of Figures
 Figure 1. Angiogenesis Assay Picture
 Figure 2. Global Angiogenesis Assay Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Angiogenesis Assay Market Share by Type: 2025 vs 2032
 Figure 4. In Vitro Assay Kit Features
 Figure 5. In Vivo Assay Kit Features
 Figure 6. Global Angiogenesis Assay Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Angiogenesis Assay Market Share by Application: 2025 vs 2032
 Figure 8. Academic Institution Case Studies
 Figure 9. Biotech Companies Case Studies
 Figure 10. Angiogenesis Assay Report Years Considered
 Figure 11. Global Angiogenesis Assay Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 12. Global Angiogenesis Assay Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Angiogenesis Assay Market Share by Region: 2025 vs 2032
 Figure 14. Global Angiogenesis Assay Market Share by Players in 2025
 Figure 15. Global Angiogenesis Assay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 16. The Top 10 and 5 Players Market Share by Angiogenesis Assay Revenue in 2025
 Figure 17. North America Angiogenesis Assay Market Size YoY Growth (US$ Million), 2021–2032
 Figure 18. North America Angiogenesis Assay Market Share by Country (2021–2032)
 Figure 19. United States Angiogenesis Assay Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. Canada Angiogenesis Assay Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Europe Angiogenesis Assay Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Angiogenesis Assay Market Share by Country (2021–2032)
 Figure 23. Germany Angiogenesis Assay Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. France Angiogenesis Assay Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. U.K. Angiogenesis Assay Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Italy Angiogenesis Assay Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Russia Angiogenesis Assay Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Ireland Angiogenesis Assay Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Asia-Pacific Angiogenesis Assay Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Angiogenesis Assay Market Share by Region (2021–2032)
 Figure 31. China Angiogenesis Assay Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Japan Angiogenesis Assay Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. South Korea Angiogenesis Assay Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Southeast Asia Angiogenesis Assay Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. India Angiogenesis Assay Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Australia & New Zealand Angiogenesis Assay Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Latin America Angiogenesis Assay Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Angiogenesis Assay Market Share by Country (2021–2032)
 Figure 39. Mexico Angiogenesis Assay Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Brazil Angiogenesis Assay Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Middle East & Africa Angiogenesis Assay Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Angiogenesis Assay Market Share by Country (2021–2032)
 Figure 43. Israel Angiogenesis Assay Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Saudi Arabia Angiogenesis Assay Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. UAE Angiogenesis Assay Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Abcam Revenue Growth Rate in Angiogenesis Assay Business (2021–2026)
 Figure 47. Bio-Techne (Trevigen, R&D Systems) Revenue Growth Rate in Angiogenesis Assay Business (2021–2026)
 Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Angiogenesis Assay Business (2021–2026)
 Figure 49. Cell Biolabs, Inc. Revenue Growth Rate in Angiogenesis Assay Business (2021–2026)
 Figure 50. BioVision, Inc Revenue Growth Rate in Angiogenesis Assay Business (2021–2026)
 Figure 51. PromoCell GmbH Revenue Growth Rate in Angiogenesis Assay Business (2021–2026)
 Figure 52. Merck KGaA Revenue Growth Rate in Angiogenesis Assay Business (2021–2026)
 Figure 53. Kollodis BioSciences Revenue Growth Rate in Angiogenesis Assay Business (2021–2026)
 Figure 54. Sartorius (Essen BioScience) Revenue Growth Rate in Angiogenesis Assay Business (2021–2026)
 Figure 55. Creative Bioarray Revenue Growth Rate in Angiogenesis Assay Business (2021–2026)
 Figure 56. ibidi GmbH Revenue Growth Rate in Angiogenesis Assay Business (2021–2026)
 Figure 57. Solarbio Revenue Growth Rate in Angiogenesis Assay Business (2021–2026)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools